S&P 500 Price Analysis – May 5 Yet again, the S&P 500 has managed to hold on to a closing rebound from its rising 13-day average, presently seen at 2880 levels. S&P 500 seems to be seeking its initial significant break following a 35 percent recovery from the lows. The World Health Organization (WHO) stays […]
S&P 500 Price Analysis – April 28 The S&P 500 is up on the optimism that coronavirus lockdown will soon end, as the Economy at least partially re-open. Consequently, at the time of writing, we see the S&P 500 rise by 1.50 percent from a low of 2858.2 to a high of 2915.0 levels. Key […]
S&P 500 Price Analysis – April 21 S&P 500 depicts the return of suspicion in the early Asian session on Tuesday, following a recent risk-on. The S&P declined 0.64 percent to 2.778.7 level and the S&P 500 upside rally lost momentum during the European session as market declines beneath 2800 level. Key Levels Resistance Levels: […]
S&P 500 Price Analysis – April 14 Guarded optimism that the global coronavirus pandemic may have begun to nosedive pushed the S&P 500 higher in the European session on Tuesday past the 2800 psychological mark during Asia session. Steady growth is likely to continue, as the COVID-19 impacts the majority of businesses. Key Levels Resistance […]
S&P 500 Price Analysis – April 7 S&P 500 rose through last week’s high level of 2638.7 pushing further past the level of 2700 in today’s session as a slowdown in new infections suggesting that the epidemic may have hit a peak and that investors and markets could have better days ahead. Key Levels Resistance […]
S&P 500 Price Analysis – April 5 In the first quarter of the financial crisis, the S&P 500 reported its worst performance, as recorded cases of coronavirus now amount to over a million globally. The S&P 500 began the new quarter after rising by 17.9% relative to its low in the last seven trading days, with […]
S&P 500 Price Analysis – March 31 The S&P 500 consolidates the 4-day advance beneath the levels of 2600/2700 while big and powerful outbreak threats linger, worldwide uncertainties stay on the weak side during Monday’s initial trading session. Tactically, as per analysts at Goldman Sachs, they reasonably expect the S&P 500 to increase to 3000 […]
S&P 500 Price Analysis – March 29 The US benchmark S&P 500 index is down to 2525 level as investors start to factor in the impact of the $2.2 trillion stimulus package for the stabilization of the economy, making it the largest tax reform package ever accepted by the US. Congress. Key Levels Resistance Levels: […]
Even though the highly contagious pandemic Corona (COVID-19) is causing havoc throughout the globe, its consequences were felt in just about all sectors of the world. Biotech firms are in a run-off against-time behind the scenes to create a pathogen vaccine. There are now many investors looking to invest in these firms. 1. GlaxoSmithKline Being […]
